Show simple item record

dc.contributor.authorLiong, Sue Y
dc.contributor.authorKochhar, Rohit
dc.contributor.authorRenehan, Andrew G
dc.contributor.authorManoharan, Prakash
dc.date.accessioned2012-12-28T16:06:58Z
dc.date.available2012-12-28T16:06:58Z
dc.date.issued2012-10
dc.identifier.citationUtility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer. 2012, 82 (10):729-36 ANZ J Surgen_GB
dc.identifier.issn1445-2197
dc.identifier.pmid22989147
dc.identifier.doi10.1111/j.1445-2197.2012.06237.x
dc.identifier.urihttp://hdl.handle.net/10541/263695
dc.description.abstractThis study aimed to evaluate the utility of 18-fluorodeoxyglucose positron emission/computed tomography (PET/CT) in the management of colorectal cancer (CRC) patients with suspected recurrence.
dc.language.isoenen
dc.rightsArchived with thanks to ANZ journal of surgeryen_GB
dc.titleUtility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Radiology, The Christie, Manchester, UK.en_GB
dc.identifier.journalANZ Journal of Surgeryen_GB
html.description.abstractThis study aimed to evaluate the utility of 18-fluorodeoxyglucose positron emission/computed tomography (PET/CT) in the management of colorectal cancer (CRC) patients with suspected recurrence.


This item appears in the following Collection(s)

Show simple item record